(G) Genpact - Overview
Stock: Outsourcing, Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.50% |
| Yield on Cost 5y | 1.73% |
| Yield CAGR 5y | 12.01% |
| Payout Consistency | 58.5% |
| Payout Ratio | 18.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | -17.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -28.92 |
| Character TTM | |
|---|---|
| Beta | 0.675 |
| Beta Downside | 0.615 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.61% |
| CAGR/Max DD | -0.10 |
Description: G Genpact January 06, 2026
Genpact Limited (NYSE:G) is a Bermuda-incorporated provider of business process outsourcing (BPO) and information-technology services, operating across India, the rest of Asia, North and Latin America, and Europe.
The firm is organized into three operating segments: Financial Services, Consumer & Healthcare, and High-Tech & Manufacturing. Each segment delivers end-to-end solutions ranging from customer onboarding and loan processing to supply-chain planning, digital commerce, and engineering support.
Key performance indicators from the most recent fiscal year show revenue of roughly **$4.0 billion**, a **5 % year-over-year growth** driven largely by digital-transformation contracts, and an **operating margin near 13 %** after continued investment in AI-enabled automation.
Sector-level drivers that underpin Genpage’s outlook include accelerating demand for **cloud-based BPO services**, heightened regulatory compliance spending in financial services, and the **near-shoring trend** that pushes U.S. firms to outsource to lower-cost but high-skill locations such as India and Eastern Europe.
Analysts note that Genpact’s **backlog of signed contracts grew 8 % YoY**, indicating a robust pipeline that could sustain earnings growth even if macro-economic conditions soften.
For a deeper, data-rich assessment of Genpact’s valuation dynamics, you might explore the company’s profile on ValueRay to see how its risk-adjusted metrics compare to peers.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 552.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.85 > 1.0 |
| NWC/Revenue: 20.75% < 20% (prev 23.42%; Δ -2.67% < -1%) |
| CFO/TA 0.14 > 3% & CFO 812.9m > Net Income 552.5m |
| Net Debt (-274.9m) to EBITDA (874.7m): -0.31 < 3 |
| Current Ratio: 1.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (175.0m) vs 12m ago -3.02% < -2% |
| Gross Margin: 36.04% > 18% (prev 0.35%; Δ 3569 % > 0.5%) |
| Asset Turnover: 93.81% > 50% (prev 95.59%; Δ -1.78% > 0%) |
| Interest Coverage Ratio: 12.91 > 6 (EBITDA TTM 874.7m / Interest Expense TTM 60.4m) |
Altman Z'' 3.10
| A: 0.18 (Total Current Assets 2.66b - Total Current Liabilities 1.60b) / Total Assets 5.84b |
| B: 0.24 (Retained Earnings 1.39b / Total Assets 5.84b) |
| C: 0.14 (EBIT TTM 779.7m / Avg Total Assets 5.42b) |
| D: 0.16 (Book Value of Equity 530.4m / Total Liabilities 3.29b) |
| Altman-Z'' Score: 3.10 = A |
Beneish M -2.98
| DSRI: 1.10 (Receivables 1.44b/1.23b, Revenue 5.08b/4.77b) |
| GMI: 0.98 (GM 36.04% / 35.45%) |
| AQI: 0.96 (AQ_t 0.48 / AQ_t-1 0.50) |
| SGI: 1.07 (Revenue 5.08b / 4.77b) |
| TATA: -0.04 (NI 552.5m - CFO 812.9m) / TA 5.84b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of G shares?
Over the past week, the price has changed by -8.47%, over one month by -15.18%, over three months by -8.43% and over the past year by -24.69%.
Is G a buy, sell or hold?
- StrongBuy: 4
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the G price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.8 | 20.9% |
| Analysts Target Price | 48.8 | 20.9% |
| ValueRay Target Price | 40.2 | -0.4% |
G Fundamental Data Overview February 08, 2026
P/E Forward = 18.315
P/S = 1.3902
P/B = 2.5545
P/EG = 1.7
Revenue TTM = 5.08b USD
EBIT TTM = 779.7m USD
EBITDA TTM = 874.7m USD
Long Term Debt = 827.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 428.2m USD (from shortTermDebt, last quarter)
Debt = 578.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -274.9m USD (from netDebt column, last quarter)
Enterprise Value = 6.34b USD (6.96b + Debt 578.9m - CCE 1.20b)
Interest Coverage Ratio = 12.91 (Ebit TTM 779.7m / Interest Expense TTM 60.4m)
EV/FCF = 8.66x (Enterprise Value 6.34b / FCF TTM 731.7m)
FCF Yield = 11.54% (FCF TTM 731.7m / Enterprise Value 6.34b)
FCF Margin = 14.40% (FCF TTM 731.7m / Revenue TTM 5.08b)
Net Margin = 10.88% (Net Income TTM 552.5m / Revenue TTM 5.08b)
Gross Margin = 36.04% ((Revenue TTM 5.08b - Cost of Revenue TTM 3.25b) / Revenue TTM)
Gross Margin QoQ = 36.56% (prev 36.37%)
Tobins Q-Ratio = 1.08 (Enterprise Value 6.34b / Total Assets 5.84b)
Interest Expense / Debt = 2.05% (Interest Expense 11.9m / Debt 578.9m)
Taxrate = 24.22% (45.7m / 188.8m)
NOPAT = 590.9m (EBIT 779.7m * (1 - 24.22%))
Current Ratio = 1.66 (Total Current Assets 2.66b / Total Current Liabilities 1.60b)
Debt / Equity = 0.23 (Debt 578.9m / totalStockholderEquity, last quarter 2.55b)
Debt / EBITDA = -0.31 (Net Debt -274.9m / EBITDA 874.7m)
Debt / FCF = -0.38 (Net Debt -274.9m / FCF TTM 731.7m)
Total Stockholder Equity = 2.53b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.20% (Net Income 552.5m / Total Assets 5.84b)
RoE = 21.81% (Net Income TTM 552.5m / Total Stockholder Equity 2.53b)
RoCE = 23.20% (EBIT 779.7m / Capital Employed (Equity 2.53b + L.T.Debt 827.0m))
RoIC = 15.69% (NOPAT 590.9m / Invested Capital 3.77b)
WACC = 7.87% (E(6.96b)/V(7.54b) * Re(8.40%) + D(578.9m)/V(7.54b) * Rd(2.05%) * (1-Tc(0.24)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF Debug] Terminal Value 81.18% ; FCFF base≈651.8m ; Y1≈775.7m ; Y5≈1.22b
Fair Price DCF = 126.1 (EV 21.21b - Net Debt -274.9m = Equity 21.48b / Shares 170.3m; r=7.87% [WACC]; 5y FCF grow 20.27% → 2.90% )
EPS Correlation: 89.48 | EPS CAGR: 13.67% | SUE: 1.69 | # QB: 6
Revenue Correlation: 95.97 | Revenue CAGR: 5.78% | SUE: 1.47 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.92 | Chg30d=+0.006 | Revisions Net=+1 | Analysts=11
EPS current Year (2026-12-31): EPS=4.00 | Chg30d=+0.050 | Revisions Net=+3 | Growth EPS=+9.6% | Growth Revenue=+7.0%
EPS next Year (2027-12-31): EPS=4.43 | Chg30d=+0.029 | Revisions Net=+2 | Growth EPS=+10.7% | Growth Revenue=+7.3%